Gene Biotherapeutics Inc Revenue Growth Rates (CRXM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Gene Biotherapeutics Inc   (CRXM)
 

CRXM's Revenue Growth by Quarter and Year

Gene Biotherapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRXM Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December 0.00
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





CRXM Revenue fourth quarter 2019 Y/Y Growth Comment
Gene Biotherapeutics Inc in the fourth quarter 2019 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2019, Gene Biotherapeutics Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Gene Biotherapeutics Inc ' s Revenue no change of 0% ranks overall at the positon no. in the fourth quarter 2019.


CRXM Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Gene Biotherapeutics Inc 's fourth quarter 2019 Revenue $ 0.00 millions CRXM's Income Statement
Gene Biotherapeutics Inc 's fourth quarter 2018 Revenue $ 0.00 millions Quarterly CRXM's Income Statement


CRXM Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to CRXM Growth rate Comparisons >> Back to CRXM Growth rate Comparisons >>


Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Gene Biotherapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CRXM's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CRXM's IV. Quarter Q/Q Revenue Comment


Gene Biotherapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Dec 31 2020 period, Gene Biotherapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Gene Biotherapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2020 period, Gene Biotherapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Gene Biotherapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CRXM's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Orthopediatrics Corp-0.15%$ -0.148 millions
Precision Optics Corporation Inc -0.40%$ -0.404 millions
Bausch Health Companies Inc -0.49%$ -0.495 millions
Biomarin Pharmaceutical Inc-0.51%$ -0.512 millions
Endo International Plc-0.60%$ -0.599 millions
Sanofi-0.70%$ -0.696 millions
Stereotaxis Inc -0.99%$ -0.987 millions
Prestige Consumer Healthcare Inc -1.14%$ -1.144 millions
Accuray Incorporated-1.38%$ -1.383 millions
Surmodics Inc -1.41%$ -1.411 millions
Integra Lifesciences Holdings Corp-1.64%$ -1.640 millions
Nanostring Technologies Inc -1.81%$ -1.811 millions
Zimmer Biomet Holdings Inc -1.90%$ -1.901 millions
Castle Biosciences Inc -1.90%$ -1.903 millions
Rockwell Medical inc -2.10%$ -2.103 millions
Delcath Systems Inc -2.12%$ -2.124 millions
Vystar Corporation-2.13%$ -2.131 millions
U S Physical Therapy Inc-2.17%$ -2.165 millions
Sientra Inc -2.44%$ -2.439 millions
Corcept Therapeutics Inc-2.46%$ -2.457 millions
Perrigo Company Plc-2.52%$ -2.517 millions
Avanos Medical Inc -2.53%$ -2.529 millions
Arcus Biosciences Inc -2.70%$ -2.697 millions
Pacific Biosciences Of California Inc -2.84%$ -2.843 millions
Orthofix Medical Inc -3.19%$ -3.189 millions
Dentsply Sirona Inc -3.19%$ -3.194 millions
Cutera Inc -3.58%$ -3.576 millions
Lifevantage Corp-3.65%$ -3.649 millions
Phibro Animal Health Corporation-3.67%$ -3.674 millions


About Gene Biotherapeutics Inc Revenue Growth Rates (CRXM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-22-009863
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Gene Biotherapeutics Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.